Table 2.
Observed CV event distribution in the studied group, according to gender and CV risk group
| CV risk calculator | < 10% | 10–20% | > 20% | ||||||
|---|---|---|---|---|---|---|---|---|---|
| N | CVD+ | %(AR) | N | CVD+ | %(AR) | N | CVD+ | %(AR) | |
| SCORE | |||||||||
| F | 336 | 24 | 7.1 | 80 | 9 | 11.3 | 149 | 33 | 22.1 |
| M | 100 | 6 | 6.0 | 61 | 14 | 23.0 | 136 | 42 | 30.9 |
| T | 436 | 30 | 6.9 | 141 | 23 | 16.3 | 285 | 75 | 26.3 |
| FRS | |||||||||
| F | 271 | 13 | 4.8 | 168 | 23 | 13.7 | 127 | 30 | 23.6 |
| M | 65 | 2 | 3.1 | 77 | 14 | 18.2 | 155 | 47 | 30.3 |
| T | 336 | 15 | 4.5 | 245 | 37 | 15.1 | 282 | 77 | 27.3 |
| QR2 | |||||||||
| F | 262 | 14 | 5.3 | 129 | 17 | 13.2 | 175 | 35 | 20.0 |
| M | 68 | 4 | 5.9 | 69 | 9 | 13.0 | 160 | 50 | 31.1 |
| T | 330 | 18 | 5.5 | 198 | 26 | 13.1 | 335 | 85 | 25.4 |
CV cardiovascular, CVD cardiovascular disease, AR absolute risk, FRS Framingham Risk Score, QR2 QRisk2, F females, M males, T total